Abstract
The evidence pointing to a viral etiology for at least some forms of human cancer, a possibility that has long been considered on the basis of animal studies, has continued to accumulate to such an extent that viral oncologists must now reevaluate their clinical and experimental data in order to consider which specific approaches are now ready for clinical trials. Although ethical restrictions continue to inhibit attempts to prove that specific viruses cause certain human tumors, as outlined by Bryan et al. (1967; Bryan, 1962), epidemiological studies have been able to suggest not only which human tumors are most likely to be caused by infectious agents (Burkitt, 1962; Cole et al., 1968; Correa and O’Conor, 1971; Heath and Hasterlik, 1963; Kessler, 1974; Levine, 1974; Levine and Gravell, 1975; Morrow et al., 1971) but some have even suggested the pattern of the agents’ transmission (Kessler, 1976; Vianna et al., 1971).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ablashi, D. V., and Pearson, G. R., 1974, Animal models: Herpesvirus saimiri, a nonhuman primate model for herpesvirus-associated neoplasia of man, Cancer Res. 34: 1232.
Anderson, L. J., and Jarrett, W. F., 1971, Membranous glomerulonephritis associated with leukemia in cats, Res. Vet. Sci. 12: 179.
Anderson, L. J., Jarrett, W. F. H., Jarrett, O., and Laird, H. M., 1971, Feline leukemia-virus infection of kittens: Mortality associated with atrophy of the thymus and lymphoid depletion, J. Natl. Cancer Inst. 47: 807.
Anderson, P. N., Klein, D. L., Bias, W. B., Mullins, G. M., Burke, P. J., and Santos, G. W., 1974, Cell-mediated immunological reactivity of patients and siblings to blast cells from adult acute leukemias, Isr. J. Med. Sci. 10: 1033.
Aurelian, L., Schumann, B., Marcus, R. L., and Davis, H. J., 1973a, Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma, Science 181: 161.
Aurelian, L., Davis, H. J., and Julian, C. G., 1973b, Herpesvirus type-2 induced tumor specific antigen in cervical carcinoma. Am. J. Epidemiol. 98: 1.
Aurelian, L., Strandberg, J. D., and Marcus, R. L., 1974, Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpes-virus type-2 induced tumor specific antigen in sera from squamous cervical carcinoma, Prog. Exp. Tumor Res. 19: 165.
Baker, C. G., Carrese, L. M., and Rauscher, F., 1966, The special virus leukemia program of the National Cancer Institute: Scientific aspects and program logic, Proc. Zool. Soc. London 17: 259.
Bates, H. A., Bankole, R. O., and Swaim, W. R., 1966, Immunofluorescent studies in human leukemia, Blood 34: 430.
Bekesi, J. G., Roboz, J. P., Walter, L., and Holland, J. F., 1974, Stimulation of specific immunity against cancer by neuraminidase-treated tumor cells, Behring Inst. Mitt. 55: 309.
Bekesi, J. G., Holland, J. F., Yates, J. W., Henderson, E., and Fleminger, R., 1975, Chemotherapy of acute myelogenous leukemia with neuraminidase treated allogeneic leukemia cells, Proc. Am. Assoc. Cancer Res. 16: 121.
Bekesi, J. G., Roboz, J. P., Zimmerman, E., and Holland, J. F., 1976, Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon, Cancer Res. 36: 631.
Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., 1972, Cytologic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia, Science 178: 304.
Biggs, P. M., Payne, L. N., Milne, B. S., Churchill, A. E., Chubb, R. C., Powell, D. G., and Harris, A. H., 1970, Field trials with an attenuated cell associated vaccine for Marek’s disease, Vet. Rec. 87: 704.
Bittner, J. J., 1952, Tumor-inducing properties of the mammary tumor agent in young and adult mice, Cancer Res. 12: 510.
Bittner, J. J., 1960, Influence of the mammary-tumor agent on the genesis of mammary cancer in agent-free mice after milk transmission, J. Natl. Cancer Inst. 25: 177.
Blair, P. B., and Lane, M-A., 1974, Immunologic evidence for horizontal transmission of MTV, J. Immunol. 113: 1446.
Bowen, J. M., McBride, C. M., Miller, M. S., and Dmochowski, I., 1976, Relationship of nucleolar antigens in malignant melanoma cells to disease prognosis, Proc. 9th Int. Pigment Cell Conf. (in press).
Bryan, W. R., 1962, The search for causative viruses in human cancer: A discussion of the problem, J. Natl. Cancer Inst. 29: 1027.
Bryan, W. R., Dalton, A. J., and Rauscher, F. J., 1967, The viral approach to human leukemia and lymphoma: Its current status, Prog. Hematol. 5: 137.
Buell, P., 1973, Changing incidence of breast cancer in Japanese-American women, J. Natl. Cancer Inst. 51: 1479.
Burkitt, D., 1962, A “tumour safari” in East and Central Africa, Br. J. Cancer 16: 17.
Chopra, H. C., and Mason, M. M., 1970, A new virus in a spontaneous mammary tumor of a Rhesus monkey, Cancer Res. 30: 2081.
Churchill, A. E., and Biggs, P. M., 1968, Herpes-type virus isolated in cell culture from tumors of chickens with Marek’s disease. II. Studies in viivo, J. Natl. Cancer Inst. 49: 951.
Churchill, A. E., Payne, L. N., and Chubb, R. C., 1969, Immunization against Marek’s disease using a live attenuated virus, Nature (London) 221: 744.
Cole, P., MacMahon, B., and Aisenberg, A., 1968, Mortality from Hodgkin’s disease in the United States, Lancet 11: 1371.
Correa, P., and O’Conor, G. T., 1971, Epidemiologic patterns of Hodgkin’s disease, Int. J. Cancer 8: 192.
Crittenden, L. B., 1976, The epidemiology of avian lymphoid leukosis, Cancer Res. 36: 570.
Eilber, F. R., and Morton, D. L., 1970, Immunologic studies of human sarcomas: Additional evidence suggesting an association sarcoma virus, Cancer 26: 588.
Epstein, M. A., 1976, Implications of a vaccine for the prevention of Epstein-Barr virus infection: Ethical and logistic considerations, Cancer Res. 36: 711.
Epstein, M. A., Achong, B. G., and Barr, Y. M., 1964, Virus particles in cultured lympho-blasts from Burkitt’s lymphoma, Lancet 1: 702.
Epstein, M. A., Rabin, H., Ball, G., Rickinson, A. B., Jarvis, J., and Melendez, L. V., 1973, Pilot experiments with EB virus in owl monkeys (Aotus Trivirgatus). II. EB virus in a cell line from an animal with reticuloproliferative disease, Int. J. Cancer 12: 319.
Essex, M., 1975, Horizontally and vertically transmitted oncornaviruses of cats, Adv. Cancer Res. 21: 175.
Evans, A. S., Niederman, J. C., and McCollum, R. W., 1968, Seroepidemiologic studies of infectious mononucleosis with EB virus, N. Engl. J. Med. 279: 1121.
Fialkow, P. J., Klein, G., Gartler, S. M., and Clifford, P., 1970, Clonal origin for individual Burkitt tumours, Lancet 1: 384.
Fink, M. A., Karon, M., Rauscher, F. J., Malmgren, R. A., and Orr, H. C., 1965, Further observations on the immunofluorescence of cells in human leukemia, Cancer 18: 1317.
Gallagher, R. E., and Gallo, R. C., 1975, Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells, Science 187: 350.
Gardner, M. B., Henderson, B. E., Estes, J. D., Rongey, R. W., Casagrande, J., Pike, M., and Huebner, R. J., 1976, The epidemiology and virology of C-type virus-associated hematological cancers and related diseases in wild mice, Cancer Res. 36: 574.
Gerber, P., Nkrumah, F. K., Prichett, R., and Kieff, E., 1976, Comparative studies of Epstein-Barr virus strains from Ghana and the United States, Int. J. Cancer 17: 71.
Geser, A., and de The, G., 1972, Does the Epstein-Barr virus play an aetiological role in Burkitt’s lymphoma? in: Oncogenesis and Herpesviruses (P. M. Biggs, G. de The, and L. N. Payne, eds.), p. 372, International Agency for Research on Cancer, Lyon, France.
Gold, P., and Freedman, S. O., 1965a, Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques, J. Exp. Med. 121: 439.
Gold, P., and Freedman, S. O., 1965b, Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med. 122: 467.
Goldenberg, G. J., and Brandes, L. J., 1976, In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor, Cancer Res. 36: 720.
Grose, C., Henle, W., Henle, G., and Feorino, P. M., 1975, Primary Epstein-Barr virus infections in acute neurologic diseases, N. Engl. J. Med. 292: 392.
Gross, L., 1951, Pathogenic properties and “vertical” transmission of mouse leukemia agent, Proc. Soc. Exp. Biol 78: 342.
Gutterman, J. U., Mvligit, G., Burgess, M. A., McCredie, K. B., Hunter, C., Freireich, E. J., and Hersh, E. M., 1974, Brief Communication: Immunodiagnosis of acute leukemia: Detection of residual disease, J. Natl Cancer Inst. 53: 389.
Hardy, W. D., Jr., Hess, P. W., MacEwen, E. G., McClelland, A. J., Zuckerman, E. E., Essex, M., Cotter, S. M., and Jarrett, O., 1976, Biology of feline leukemia virus in the natural environment, Cancer Res. 36: 582.
Heath, C. W., Jr., and Hasterlik, R. J., 1963, Leukemia among children in a suburban community, Am. J. Med. 34: 796.
Hellström, I. E., Hellström, K. E., Pierce, G. E., and Bill, A. H., 1968, Demonstration of cell-bound and humoral immunity against neuroblastoma cells, Proc. Natl Acad. Sci. U.S.A. 60: 1231.
Henle, G., Henle, W., Clifford, P., Diehl, V., Kafuko, G. W., Kirya, B. G., Klein, G., Morrow, R. H., Munube, G. M. R., Pike, P., Tukei, P. M., and Ziegler, J. L., 1969, Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups, J. Natl Cancer Inst. 43: 1147.
Henle, G., Henle, W., and Klein, G., 1971a, Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells, Int. J. Cancer 8: 272.
Henle, G., Henle, W., Klein, G., Gunven, P., Clifford, P., Morrow, R. H., and Ziegler, J. L., 1971b, Antibodies to early Epstein-Barr virus-induced antigens in Burkitt’s lymphoma, J. Natl Cancer Inst. 46: 861.
Henle, W., and Henle, G., 1972, Epstein-Barr virus: The cause of infectious mononucleosis—A review, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. de The, and L. N. Payne, eds.), p. 269, International Agency for Research on Cancer, Lyon, France.
Henle, W., and Henle, G., 1973a, Evidence for an oncogenic potential of the Epstein-Barr virus, Cancer Res. 33: 1419.
Henle, W., and Henle, G., 1973b, Epstein-Barr virus-related serology in Hodgkin’s disease, J. Natl Cancer Inst. Monogr. 36: 79.
Henle, W., Henle, G., Niederman, J. C., Klemola, E., and Haltia, K., 1971, Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis, J. Infect. Dis. 124: 58.
Henle, W., Henle, G., Gunven, P., Klein, G., Clifford, P., and Singh, S., 1973a, Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt’s lymphoma. Comparison of dying patients with long-term survivors, J. Natl Cancer Inst. 50: 1163.
Henle, W., Ho, H.-C., Henle, G., and Kwan, H. C., 1973b, Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors, J. Natl Cancer Inst. 51: 361.
Henle, W., Henle, G. E., and Horwitz, C. A., 1974, Epstein-Barr virus specific diagnostic tests in infectious mononucleosis, Hum. Pathol 5: 551.
Hersh, E. M., Gutterman, J. U., Mavligit, G., Gschwind, C. R., Freireich, E. J., Levine, P. H., and Plata, E. J., 1974a, Human immune response to active immunization with Rauscher leukemia virus. I. Cell-mediated and cell-associated immunity, J. Natl Cancer Inst. 53: 317.
Hersh, E. M., Hanna, M. G., Jr., Gutterman, J. U., Mavligit, G., Yurconic, M., Jr., and Gschwind, C. R., 1974, Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity, J. Natl Cancer Inst. 53: 327.
Hinze, H. C., 1971, New member of the herpesvirus group isolated from wild cottontail rabbits, Infect. Immun. 3: 350.
Hirshaut, Y., Glade, P., Viera, L. O. B. D., Ainbender, E., Dvorak, B., and Siltzbach, L. F., 1970, Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection, New Engl. J. Med. 283: 502.
Hirshaut, Y., Pei, D. T., Marcove, R. C., Mukherji, B., Spielvogel, A. R., and Essner, E., 1974, Seroepidemiology of human sarcoma antigen (S1), New Engl. J. Med. 291: 1103.
Holland, J. F., 1976, Immunological control of human leukemia: Discussion, Cancer Res. 36: 657.
Holland, J. F., and Bekesi, J. G., 1976, Immunotherapy of human leukemia with neuraminidase modified cells, in: Symposium on immunotherapy in malignant diseases, Medical Clinics of North America, Vol. 60 (W. Terry, ed.), pp. 539–549.
Hollinshead, A. C., Melnick, J. L., and Rawls, W. E., 1971, Reactivity between herpesvirus type 2-related soluble membrane antigens in cells from carcinoma of the cervix, vulva, and vagina and matched cancer and control sera, Int. Virol. 2: 105.
Hollinshead, A. C., Lee, O., Chretien, P. B., Tarpley, J. L., Rawls, W. E., and Adam, E., 1973, Antibodies to herpesvirus nonvirion antigens in squamous carcinomas, Science 182: 713.
Hollinshead, A. C., Chretien, P. B., Lee, O., Tarpley, J. L., Kerney, S. E., Silverman, N. A., and Alexander, J. C., 1976, In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens, Cancer Res. 36: 821.
Huang, D. O., Ho, J. H. C., Henle, W., and Henle, G., 1974, Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies, Int. J. Cancer 14: 580.
Huebner, R. J., and Todaro, G. J., 1969, Oncogenes of RNA tumor viruses as determinants of cancer, Proc. Natl. Acad. Sci. U.S.A. 19: 1087.
Hunt, R. D., Garcia, F. G., Barahona, H. H., King, N. W., Fraser, C. E. O., and Melendez, L. V., 1973, Spontaneous herpesvirus saimiri lymphoma in an owl monkey, J. Infect. Dis. 127: 723.
Ioannides, A. K., Rosner, F., Brenner, M., and Lee, S. L., 1968, Immunofluorescent studies of human leukemic cells with antiserum to a murine leukemic virus (Rauscher strain), Blood 31: 381.
Jarrett, W., Jarrett, O., Mackey, L., Laird, H., Hardy, W., Jr., and Essex, M., 1973, Horizontal transmission of leukemia virus and leukemia in the cat, J. Natl. Cancer Inst. 51: 833.
Johansson, B., Klein, G., Henle, W., and Henle, G., 1970, Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin’s disease, Int. J. Cancer 6: 450.
Johansson, B., Klein, G., Henle, W., and Henle, G., 1971, Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma, Int. J. Cancer 8: 475.
Kaaden, O. R., and Dietzschold, B., 1974, Alterations of the immunological specificity of plasma membranes of cells infected with Marek’s disease and turkey herpes viruses, J. Gen. Virol. 25: 1.
Kessler, I. I., 1974, Perspectives on the epidemiology of cervical cancer with specific reference to the herpesvirus hypothesis, Cancer Res 34: 1091.
Kessler, I. I., 1976, Human cervical cancer as a venereal disease, Cancer Res. 36: 783.
Klein, E., Klein, G., and Levine, P. H., 1976, Immunological control of human lymphoma: Discussion, Cancer Res. 36: 724.
Klein, G., 1973, The Epstein-Barr virus, in: The Herpesviruses ( A. S. Kaplan, ed.), p. 521, Academic Press, New York.
Klein, G., Clifford, P., Henle, G., Henle, W., Geering, G., and Old, L. J., 1969, EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence, Int. J. Cancer 4: 416.
Laufs, R., and Steinke, H., 1975, Vaccination of non-human primates against malignant lymphoma, Nature (London) 53: 71.
Lesnick, F., and Ross, L. J. N., 1975, Immunization against Marek’s disease using Marek’s disease virus-specific antigens free from infectious virus, Int. J. Cancer 16: 153.
Levine, P. H., 1974, The etiology of Hodgkin’s disease, Pathobiol. Annu. 64: 143.
Levine, P. H., and Gravell, M., 1975, The viral etiology of leukemia, Mod. Probl. Paediatr. 16: 137.
Levine, P. H., Ablashi, D. V., Berard, C. W., Carbone, P. P., Waggoner, D. E., and Malan, L., 1971a, Elevated antibody titers to Epstein-Barr virus in Hodgkin’s disease, Cancer 27: 416.
Levine, P. H., Merrill, D. A., Bethlenfalvay, N. C., Dabich, L., Stevens, D. A., and Waggoner, D. E., 1971b, A longitudinal comparison of antibodies to Epstein-Barr virus and clinical parameters in chronic lymphocytic leukemia and chronic myelocytic leukemia, Blood 38: 479.
Levine, P. H., Herberman, R. B., Rosenberg, E. B., McClure, P. D., Roland, A., Pienta, R. J., and Ting, R. C. Y., 1972a, Acute leukemia in identical twins: Search for viral and leukemia-associated antigens, Natl. Cancer Inst. 49: 943.
Levine, P. H., O’Conor, G. T., and Berard, C. W., 1972b, Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt’s lymphoma, Cancer 30: 610.
Levine, P. H., Fraumeni, J. F., Jr., Reisher, J. I., and Waggoner, D. E., 1974, Antibodies to Epstein-Barr virus-associated antigens in relatives of cancer patients, J. Natl. Cancer Inst. 52: 1037.
Li, F. P., Melvin, K. E. W., Tashjian, A. H., Jr., Levine, P. H., and Fraumeni, J. F., Jr., 1974, Brief communication: Familial medullary thyroid carcinoma and pheochromocytoma: Epidemiologic investigations, J. Natl. Cancer Inst. 52: 285.
Mackey, L., 1975, Feline leukaemia virus and its clinical effects in cats, Vet Rec. 96: 5.
Mann, D. L., Halterman, R., and Leventhal, B., 1974, Acute leukemia associated antigens, Cancer 34: 1446.
McGrath, C. M., Grant, P. M., Soule, H. D., Glancy, T., and Rich, M. A., 1974, Replication of oncornavirus-like particle in human breast carcinoma cell line, MCF-7, Nature (London) 252: 247.
Melendez, L. V., Daniel, M. D., Hunt, R. D., and Garcia, F. G., 1968. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (saimiri sciureus), Lab. Anim. Care 18: 374.
Metzgar, R. S., Mohankumar, T., and Miller, D. S., 1972, Antigens specific for human lymphocytic and myeloid leukemia cells: Detection by nonhuman primate antiserums, Science 178: 986.
Meyer, H. M., Jr., and Ennis, F. A., 1976, Regulatory approach toward vaccines against cancer: The benefit/risk ratio, Cancer Res. 36: 865.
Miller, G., 1974, The oncogenicity of Epstein-Barr virus, J. Infect. Dis. 130: 187.
Mohanakumar, T., Metzgar, R. S., and Miller, D. S., 1974, Human leukemia cell antigens: Serologic characterization with xenoantisera, J. Natl. Cancer Inst. 52: 1435.
Morrow, R. H., Pike, M. C., Smith, P. G., Ziegler, J. L., and Kisuule, A., 1971, Burkitt’s lymphoma: A time-space cluster of cases in Bwamba County of Uganda, Br. Med. J. 2: 491.
Morrow, R. H., Gutensohn, N., and Smith, P. G., 1976a, Epstein-Barr virus-malaria interaction models for Burkitt’s lymphoma: Implications for preventive trials, Cancer Res. 36: 667.
Morrow, R. H., Kisuule, A., Pike, M. C., and Smith, P. G., 1976b, Burkitt’s lymphoma in the Mengo District of Uganda: Epidemiological features and their relationship to malaria, J. Natl Cancer Inst. 56: 479.
Morton, D. L., and Malmgren, R. A., 1968, Human osteosarcomas: Immunologic evidence suggesting an associated infectious agent, Science 162: 1279.
Morton, D. L., Malmgren, R. A., Holmes, E. C., and Ketcham, A. S., 1968, Demonstration of antibodies against human malignant melanoma by immunofluorescence, Surgery 64: 233.
Morton, D. L., Hall, W. T., and Malmgren, R. A., 1969, Human liposarcomas: Tissue cultures containing foci of transformed cells with viral particles, Science 165: 813.
Mukherji, B., and Hirshaut, Y., 1973, Evidence for fetal antigen in human sarcoma, Science 181: 440.
Nahmias, A. J., Josey, W. E., Naib, Z. M., Luce, C., and Duffey, C., 1970, Antibodies to herpesvirus hominis type 1 and 2 in humans. I. Patients with genital herpetic infections, Am. J. Epidemiol. 91: 539.
Nooter, K., Aarssen, A. M., Bentvelzen, P., Degroot, F. G., and Van Pelt, F. G., 1975, Isolation of infectious C-type oncornavirus from human leukaemic bone marrow cells, Nature (London) 256: 595.
O’Conor, G. T., 1970, Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt’s Tumor, Am. J. Med. 48: 279.
Padgett, B. L., Walker, D. L., Zurhein, G. M., Eckroade, R. J., and Dessel, B. H., 1971, Cultivation of Papova-like virus from human brain with progressive multifocal leucoencephalopathy, Lancet 1: 1257.
Panem, S., Prochownik, E. V., Reale, F. R., and Kirsten, W. H., 1975, Isolation of Type-C virions from a normal human fibroblast strain, Science 189: 297.
Pasca, A. S., Kummerlander, L., Pejtsik, B., and Pali, K., 1975, Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls, J. Natl Cancer Inst. 55: 775.
Priori, E. S., and Dmochowski, L., 1974, Immunofluorescence antibodies in human sera to antigens in cells of a type C virus producing human culture of tumor origin, Prog. Exp. Tumor Res. 19: 182.
Priori, E. S., Dmochowski, L., Myers, B., and Wilbur, J. R., 1971a, Continuous type C virus production in a tissue culture of human origin (Burkitt lymphoma), 29th Ann. Proc. Electron Microsc. Soc., p. 376.
Priori, E. S., Seman, G., Dmochowski, L., Gallager, H. S., and Anderson, D. E., 1971b, Immunofluorescence studies on sera of patients with breast carcinoma, Cancer 28: 1462.
Priori, E. S., Wilbur, J. R., and Dmochowski, L., 1971c, Immunofluorescence tests on sera of patients with osteogenic sarcoma, J. Natl Cancer Inst. 46: 1299.
Priori, E. S., Anderson, D. E., Williams, W. C., and Dmochowski, L., 1972, Immunological studies on human breast carcinoma and mouse mammary tumors, J. Natl Cancer Inst. 48: 1131.
Purchase, H. G., 1976, Prevention of Marek’s disease: A review, Cancer Res. 36: 696.
Rabin, H., Neubauer, R. H., Pearson, G. R., Cicmanec, J. L., Wallen, W. C., Loeb, W. F., and Valerio, M. G., 1975, Spontaneous lymphoma associated with herpesvirus saimiri in owl monkeys, J. Natl Cancer Inst. 54: 499.
Reedman, B. M., Klein, G., Pope, J. H., Walters, M. K., Hilgers, J., Singh, S., and Johansson, B., 1974, Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies, Int. J. Cancer 13: 755.
Roizman, B., and Frenkel, N., 1975, Does genital herpes cause cancer? A midway assessment, in: Sexually Transmitted Diseases ( R. D. Catterrall and C. S. Nicol, eds.), p. 151, Academic Press, New York.
Rosenberg, E. B., Herberman, R. B., Levine, P. H., Halterman, R. H., McCoy, J. L., and Wunderlich, J. R., 1972, Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins, Int. J. Cancer 9: 648.
Royston, I., and Aurelian, L., 1970, Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma, Proc. Natl. Acad. Sci. U.S.A. 67: 204.
Sabin, A. B., 1974, Herpes simplex-genitalis virus nonvirion antigens and their implication in certain human cancers: unconfirmed, Proc. Natl. Acad. Sci. U.S.A. 71: 3248.
Shope, T., Dechairo, D., and Miller, G., 1973, Malignant lymphoma in cottontip marmosets after inoculation with Epstein-Barr virus, Proc. Nat. Acad. Sci. U.S.A. 70: 2487.
Smith, P. G., and Pike, M. C., 1976, Current epidemiological evidence for transmission of Hodgkin’s disease, Cancer Res. 36: 660.
Sohier, R., and de The, G., 1972, Evolution of complement-fixing antibody titers with the development of Burkitt’s lymphoma, Int. J. Cancer 9: 524.
Tarro, G., and Sabin, A. B., 1970, Virus-specific, labile, non-virion antigen in herpesvirus-infected cells, Proc. Natl. Acad. Sci. U.S.A. 65: 753.
Tarro, G., and Sabin, A. B., 1973, Nonvirion antigens produced by herpes simplex viruses 1 and 2, Proc. Natl. Acad. Sci. U.S.A. 70: 1032.
Teich, N. M., Weiss, R. A., Salahuddin, S. Z., Gallagher, R. E., Gillespie, D. H., and Gallo, R. C., 1975, Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells, Nature (London) 256: 551.
Theilen, G. H., Gould, D., Fowler, M., and Dungworth, D. L., 1971, C-type virus in tumor tissue of a woolly monkey (Logothrix spp.) with fibrosarcoma, J. Natl. Cancer Inst. 47: 881.
Thomas, E. D., Bryant, J. I., Buckner, C. D., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P., Ramberg, R. E., and Storb, R., 1972, Leukaemic transformation of engrafted human marrow cells in vivo, Lancet 1: 1310.
Tischendorf, P., Shramek, G. J., Balagtas, R. C., Deinhardt, F., Knospe, W. H., Noble, G. R., and Maynard, J. E., 1970, Development and Persistence of Immunity to Epstein-Barr virus in man, J. Infect. Dis. 122: 401.
Van Blitterswijk, W. J., Emmelot, P., Hilgers, J., Kamlag, D., Nusse, R., Feltkamp, C. A., 1975, Quantitation of virus induced (MLr) and normal (THY. 1.2) cell surface antigens in isolated plasma membranes and the extracellular ascites fluid of mouse leukemia cells, Cancer Res. 35: 2743.
Vianna, N. J., Greenwald, P., and Davies, J. N. P., 1971, Nature of Hodgkin’s disease agent, Lancet 1: 733.
Williams, E. H., Day, N. E., and Geser, A. G., 1974, Seasonal variation in onset of Burkitt’s lymphoma in the West Nile district of Uganda, Lancet 11: 19.
Witter, R. L., 1976, Natural mechanisms of controlling lymphotropic herpesvirus infection (Marek’s disease) in the chicken, Cancer Res. 36: 681.
Yohn, D. S., Horoszewicz, J. S., Ellison, R. R., Mittelman, A., Chai, L. S., and Grace, J. T., Jr., 1968, Immunofluorescent studies in human leukemia, Cancer Res. 28: 1692.
Ziegler, J. L., Bluming, A. Z., Fass, L., and Morrow, R. H., Jr., 1972, Relapse patterns in Burkitt’s lymphoma, Cancer Res. 32: 1267.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Levine, P.H. (1977). Clinical Implications of Immunity to Oncogenic Viruses. In: Hanna, M.G., Rapp, F. (eds) Contemporary Topics in Immunobiology. Contemporary Topics in Immunobiology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3051-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3051-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3053-0
Online ISBN: 978-1-4684-3051-6
eBook Packages: Springer Book Archive